RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GIORDA CB
Collezione ASL Torino 5

Items : 67

Feasibility and accuracy of the screening for diabetic retinopathy using a fundus camera and an artificial intelligence pre-evaluation application. in Acta diabetologica / Acta Diabetol. 2024 Jan;61(1):63-68. doi: 10.1007/s00592-023-02172-2. Epub 2023 Sep 7.

2024
ASL Torino 5

Giorda CB; Nada E; Tartaglino B; Manti R; Doglio M; Romeo F; Piatti A;

Diabetic retinopathy screening with confocal fundus camera and artificial intelligence - assisted grading. in European journal of ophthalmology / Eur J Ophthalmol. 2024 Aug 7:11206721241272229. doi: 10.1177/11206721241272229.

2024
ASL Torino 5

Nada E; Doglio M; Manti R; Romeo F; Tartaglino B; Gazzina S; Rui C; Piatti A; Giorda CB;

Hospitalisation for herpes zoster in people with and without diabetes: A 10-year-observational study. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2024 Apr;210:111603. doi: 10.1016/j.diabres.2024.111603. Epub 2024 Mar 8.

2024
ASL Torino 5
ASL Torino 3

Gnavi R; Costa G; Romeo F; Picariello R; Tartaglino B; Nada E; Giorda CB;

An update on the incidence of type 1 diabetes during the COVID-19 pandemic years. in Diabetes, obesity & metabolism / Diabetes Obes Metab. 2023 Oct;25(10):3068-3070. doi: 10.1111/dom.15182. Epub 2023 Jul 3.

2023
ASL Torino 3
ASL Torino 5

Giorda CB; Gnavi R; Tartaglino B; Favella L; Romeo F; Rabbone I; Migliardi A; Ferro S;

Correction to: Increased incidence of type 1 diabetes in 2 years of COVID?19 pandemic. in Acta diabetologica / Acta Diabetol. 2023 May;60(5):719. doi: 10.1007/s00592-023-02072-5.

2023
ASL Torino 3
ASL Torino 5

Rabbone I; Migliardi A; Favella L; Manti R; Tartaglino B; Gnavi R; Giorda CB; Ferro S;

Hepatocellular carcinoma in a large cohort of type 2 diabetes patients. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2023 Jun;200:110684. doi: 10.1016/j.diabres.2023.110684. Epub 2023 Apr 24.

2023
ASL Torino 3
ASL Torino 5

Monge L; Gnavi R; Manti R; Nada E; Costa G; Tartaglino B; Giorda CB; Picariello R;

Increased incidence of type 1 diabetes in 2 years of COVID-19 pandemic. in Acta diabetologica / Acta Diabetol. 2023 Apr;60(4):587-589. doi: 10.1007/s00592-022-01986-w. Epub 2022 Dec 17.

2023
ASL Torino 5
ASL Torino 3

Rabbone I; Ferro S; Favella L; Migliardi A; Manti R; Tartaglino B; Giorda CB; Gnavi R;

Achieving Good Metabolic Control Without Weight Gain with the Systematic Use of GLP-1-RAs and SGLT-2 Inhibitors in Type 2 Diabetes: A Machine-learning Projection Using Data from Clinical Practice in Clinical Therapeutics

2023
ASL Torino 5

Giorda CB; Rossi A; Baccetti F; Zilich R; Romeo F; Besmir N; Di Cianni G; Guaita G; Morviducci L; Muselli M; Ozzello A; Pisani F; Ponzani P; Santin P; Verda D; Musacchio N;

Correction to: Increased incidence of type 1 diabetes in 2 years of COVID?19 pandemic (Acta Diabetologica, (2022), 60, 4, (587-589), 10.1007/s00592-022-01986-w) in Acta Diabetologica

2023
ASL Torino 5

Giorda CB; Gnavi R; Tartaglino B; Manti R; Migliardi A; Favella L; Ferro S; Rabbone I;

Instructive lessons from the analysis of assistance in diabetes during the first phase of COVID-19 pandemic. in Acta diabetologica / Acta Diabetol. 2022 Jun;59(6):861-864. doi: 10.1007/s00592-022-01855-6. Epub 2022 Feb 19.

2022
ASL Torino 4
ASL Torino 5
ASL Torino 3

Gnavi R; Romeo F; Doglio M; Nada E; Landriscina T; Giorda CB; Picariello R; Tartaglino B;

Hepatic fibrosis of any origin in a large population of type 2 diabetes patients. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2021 Sep 22;31(10):2887-2894. doi: 10.1016/j.numecd.2021.06.020. Epub 202

2021
ASL Torino 5
ASL Torino 3

Romeo F; Costa G; Giorda CB; Linzalata C; Nada E; Tartaglino B; Picariello R; Gnavi R;

From swab testing to health outcomes within the T2DM population: Impact of diabetes background on COVID19 progression. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2021 Oct;180:109021. doi: 10.1016/j.diabres.2021.109021. Epub 2021 Aug 23.

2021
ASL Torino 5
ASL Torino 3

Gnavi R; Romeo F; Costa G; Doglio M; Nada E; Tartaglino B; Picariello R; Giorda CB;

Effects of linagliptin on left ventricular DYsfunction in patients with type 2 DiAbetes and concentric left ventricular geometry: results of the DYDA 2 trial. in European journal of preventive cardiology / Eur J Prev Cardiol. 2021 Mar 23;28(1):8-17. doi: 10.1177/2047487320939217. Epub 2020 Jul 28.

2021
ASL Torino 5

Latini R; Mancusi C; Ognibeni F; Lucci D; Nada E; Giorda CB; Cioffi G; Maggioni AP;

Determinants of good metabolic control without weight gain in type 2 diabetes management: a machine learning analysis. in BMJ open diabetes research & care / BMJ Open Diabetes Res Care. 2020 Sep;8(1):e001362. doi: 10.1136/bmjdrc-2020-001362.

2020
ASL Torino 5
ASL Torino 4

Musacchio N; Guaita G; Ponzani P; Russo G; De Micheli A; Pisani F; Giorda CB; Zilich R;

Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study. in Diabetes therapy : research, treatment and education of diabetes and related disorders / Diabetes Ther. 2020 Sep;11(9):2105-2119. doi: 10.1007/s13300-020-00871-5. Epub 2020 Jul 30.

2020
ASL Torino 5
AOU San Luigi di Orbassano

Gilio B; Cercone S; Guerzoni C; Bossi AC; De Cosmo S; Orsi E; Giorda CB; Cavalot F;

Incidence of hospitalization and mortality in patients with diabetic foot regardless of amputation: a population study. in Acta diabetologica / Acta Diabetol. 2020 Feb;57(2):221-228. doi: 10.1007/s00592-019-01412-8. Epub 2019 Aug 29.

2020
ASL Torino 5
AOU Città della Salute di Torino
ASL Torino 3

Boffano GM; Giorda CB; Broglio F; Carnà P; Monge L; Gnavi R;

Incretin-based therapy and risk of cholangiocarcinoma: a nested case-control study in a population of subjects with type 2 diabetes. in Acta diabetologica / Acta Diabetol. 2020 Apr;57(4):401-408. doi: 10.1007/s00592-019-01444-0. Epub 2019 Nov 5.

2020
ASL Torino 5
ASL Torino 3

Nada E; Gnavi R; Costa G; Tartaglino B; Picariello R; Giorda CB;

[2019 ESC Guidelines on diabetes, pre-diabetes and cardiovascular diseases: what's new? The diabetologist's point of view]. in Giornale italiano di cardiologia (2006) / G Ital Cardiol (Rome). 2020 Apr;21(4):252-255. doi: 10.1714/3328.32983.

2020
ASL Torino 5

Giorda CB;

Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population. in Cardiovascular drugs and therapy / Cardiovasc Drugs Ther. 2019 Oct;33(5):547-555. doi: 10.1007/s10557-019-06898-6.

2019
ASL Torino 5

Maggioni AP; Latini R; Mancusi C; Ognibeni F; Nada E; Lucci D; Cioffi G; Giorda CB;

Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2019 Jul;29(7):736-743. doi: 10.1016/j.numecd.2019.04.009. Epub 2019 May

2019
ASL Torino 5
ASL Torino 4
ASL Torino 3

Lucisano G; Giorda CB; Romeo F; Baccetti F; Gentile FM; Rossi MC; Nicolucci A; Chiambretti A; Aglialoro A; Gentile S; Ozzello A;

Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2019 Aug 1;104(8):3296-3302. doi: 10.1210/jc.2019-00361.

2019
ASL Torino 5

Riccardi G; Maggioni AP; Mocarelli P; Squatrito S; Giorda CB; Rivellese AA; Del Prato S; Bonora E; Masulli M; Lucisano G; Vaccaro O; Nicolucci A;

Beta cell stress in a 4-year follow-up of patients with type 2 diabetes: A longitudinal analysis of the BetaDecline Study. in Diabetes/metabolism research and reviews / Diabetes Metab Res Rev. 2018 Sep;34(6):e3016. doi: 10.1002/dmrr.3016. Epub 2018 May 21.

2018
ASL Torino 5

Cucinotta D; Cercone S; De Cosmo S; Nicolucci A; Giorda CB; Russo GT;

Ten-year comparative analysis of incidence, prognosis, and associated factors for dialysis and renal transplantation in type 1 and type 2 diabetes versus non-diabetes. in Acta diabetologica / Acta Diabetol. 2018 Jul;55(7):733-740. doi: 10.1007/s00592-018-1142-y. Epub 2018 Apr 20.

2018
ASL Torino 5
ASL Torino 3

Gnavi R; Giorda CB; Tartaglino B; Costa G; Picariello R; Salomone M; Carnà P;

Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2018 Jan;135:65-72. doi: 10.1016/j.diabres.2017.10.023. Epub 2017 Oct 31.

2018
ASL Torino 5

Giorda CB; Forlani G; Manti R; Mazzotti A; De Cosmo S; Rossi MC; Nicolucci A; Di Bartolo P; Ceriello A; Guida P; Tartaglino B; Russo G;

Portrait of women with type 1 or type 2 diabetes of childbearing age attending diabetes clinics in Italy: the AMD-Annals initiative. in Acta diabetologica / Acta Diabetol. 2018 Feb;55(2):193-199. doi: 10.1007/s00592-017-1076-9. Epub 2017 Dec 5.

2018
ASL Torino 5

Scavini M; Rossi MC; Scardapane M; Nicolucci A; Manicardi V; Russo G; Di Bartolo P; Giorda CB; Musacchio N; Ceriello A; Genovese S; Molinari C; Dozio N;

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. in The lancet. Diabetes & endocrinology / Lancet Diabetes Endocrinol. 2017 Nov;5(11):887-897. doi: 10.1016/S2213-8587(17)30317-0. Epub 2017 Se

2017
ASL Torino 5
AO Cuneo
ASL Città di Torino

Riccardi G; di Bartolo P; Fornengo P; Calabrese M; Consoli A; Vedovato M; Zavaroni D; De Cosmo S; Santini C; Gnasso A; Giorgino F; Antenucci D; Ricci L; Citro G; Bossi AC; Anichini R; Dotta F; Di Benedetto A; Pugliese G; Tonutti L; Cannarsa E; Dall'Aglio E; Lauro D; Leotta S; Boemi M; Iovine C; Zamboni C; Scaranna C; Cordera R; et alii...

Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2017 Mar;27(3):209-216. doi: 10.1016/j.numecd.2016.10.005. Epub 2016 Nov

2017
ASL Torino 5
ASL Torino 4
ASL Torino 3

Romeo F; Lucisano G; Nicolucci A; Baccetti F; Gentile FM; Chiambretti A; Aglialoro A; Giorda CB; Gentile S; Ozzello O; Rossi MC;

Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study. in Clinical nutrition (Edinburgh, Scotland) / Clin Nutr. 2017 Dec;36(6):1686-1692. doi: 10.1016/j.clnu.2016.11.002. Epub 2016 Nov 14.

2017
ASL Torino 5

Riccardi G; Rivellese AA; Zamboni C; Trevisan R; Tonutti L; Signorini S; Laviola L; Mazzucchelli C; Lauro D; Lapolla A; Iovine C; Iannarelli R; Giordano C; Grioni S; Gregori G; Di Cianni G; Fontana L; Dall'Aglio E; D'Angelo F; Corsi L; Cocozza S; Clemente G; Cigolini M; Cannarsa E; Cignarelli M; Buzzetti R; Babini AC; Bani L; Auciello S; et alii...

Sex differences in food choices, adherence to dietary recommendations and plasma lipid profile in type 2 diabetes - The TOSCA.IT study. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2016 Oct;26(10):879-85. doi: 10.1016/j.numecd.2016.04.006. Epub 2016 Apr

2016
ASL Torino 5

Signorini S; Riccardi G; Cappellini F; Zogheri A; Krogh V; Zamboni C; Tonutti L; Scaranna C; Sartore G; Ruffo MC; Salvi L; Rinaldi ME; Perriello G; Mori M; Montani V; Mazzucchelli C; Mancastroppa G; Longhitano S; Iovine C; Grioni S; Giorda CB; Giordano C; Garofolo M; Fontana L; Di Cianni G; Di Bartolo P; De Gregorio A; Corsi L; Consoli A; et alii...

Incidence and correlated factors of beta cell failure in a 4-year follow-up of patients with type 2 diabetes: a longitudinal analysis of the BETADECLINE study. in Acta diabetologica / Acta Diabetol. 2016 Oct;53(5):761-7. doi: 10.1007/s00592-016-0868-7. Epub 2016 May 18.

2016
ASL Torino 5

Nicolucci A; Cucinotta D; Giorda CB; De Cosmo S; Cercone S; Russo GT;

Results of the Adequacy of glycemiC Control in pAtients with type 2 Diabetes mEllitus treated with Metformin monotherapY at the maximal-tolerated dose (ACCADEMY) study. in Endocrine / Endocrine. 2016 Jun;52(3):507-15. doi: 10.1007/s12020-015-0692-9. Epub 2015 Aug 15.

2016
ASL Torino 5

Giorda CB; Nada E; Cercone S;

Gender-Disparities in Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals Initiative. in PloS one / PLoS One. 2016 Oct 3;11(10):e0162960. doi: 10.1371/journal.pone.0162960. eCollection 2016.

2016
ASL Torino 5

Rossi MC; Lucisano G; Nicolucci A; Suraci C; Musacchio N; Giorda CB; Li Volsi P; Torlone E; Russo G; Napoli A; Manicardi V;

Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors. in PloS one / PLoS One. 2016 Oct 5;11(10):e0157915. doi: 10.1371/journal.pone.0157915. eCollection 2016.

2016
ASL Torino 5

Corona G; Giorda CB; Cucinotta D; Guida P; Nada E;

Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study. in Acta diabetologica / Acta Diabetol. 2015 Oct;52(5):845-53. doi: 10.1007/s00592-015-0713-4. Epub 2015 Feb 12.

2015
ASL Torino 5
ASL Torino 4
ASL Torino 3

Rossi MC; Nicolucci A; Lucisano G; Chiambretti A; Baccetti F; Gentile FM; Gentile S; Aglialoro A; Ozzello A; Giorda CB;

Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies. in Endocrine / Endocrine. 2015 Mar;48(2):461-71. doi: 10.1007/s12020-014-0386-8. Epub 2014 Aug 22.

2015
ASL Torino 5
ASL Torino 3

Gnavi R; Baldi I; Marafetti L; Sacerdote C; Nada E; Giorda CB;

Hospitalisation for heart failure and mortality associated with dipeptidyl peptidase 4 (DPP-4) inhibitor use in an unselected population of subjects with type 2 diabetes: a nested case-control study. in BMJ open / BMJ Open. 2015 Jun 5;5(6):e007959. doi: 10.1136/bmjopen-2015-007959.

2015
ASL Torino 5
ASL Torino 3

Gnavi R; Di Noi F; Picariello R; Alessiato A; Marafetti L; Tartaglino B; Costa G; Giorda CB;

A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position. in Diabetes, obesity & metabolism / Diabetes Obes Metab. 2014 Nov;16(11):1041-7. doi: 10.1111/dom.12297. Epub 2014 Apr 29.

2014
ASL Torino 5
ASL Torino 3

Marafetti L; Tartaglino B; Nada E; Gnavi R; Giorda CB;

Improving quality of care in people with Type 2 diabetes through the Associazione Medici Diabetologi-annals initiative: a long-term cost-effectiveness analysis. in Diabetic medicine : a journal of the British Diabetic Association / Diabet Med. 2014 May;31(5):615-23. doi: 10.1111/dme.12366. Epub 2013 Dec 24.

2014
ASL Torino 5

Hunt B; Valentine WJ; Vespasiani G; Kristiansen CK; Pellegrini F; Nicolucci A; Giorda CB;

Comparison of direct costs of type 2 diabetes care: different care models with different outcomes. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2014 Jul;24(7):717-24. doi: 10.1016/j.numecd.2014.01.009. Epub 2014 Jan 2

2014
ASL Torino 5
ASL Torino 3

Costa G; Gnavi R; Petrelli A; Marafetti L; Picariello R; Tartaglino B; Nada E; Giorda CB;

Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study. in The lancet. Diabetes & endocrinology / Lancet Diabetes Endocrinol. 2014 Feb;2(2):111-5. doi: 10.1016/S2213-8587(13)70147-5. Epub 2013 Nov 1

2014
ASL Torino 5
ASL Torino 3

Gnavi R; Marafetti L; Costa G; Tartaglino B; Giorda CB; Nada E; Picariello R;

Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature. in Endocrine / Endocrine. 2014 Aug;46(3):406-19. doi: 10.1007/s12020-014-0179-0. Epub 2014 Feb 8.

2014
ASL Torino 5

Giorda CB; Nada E; Tartaglino B;

Factors associated with beta-cell dysfunction in type 2 diabetes: the BETADECLINE study. in PloS one / PLoS One. 2014 Oct 27;9(10):e109702. doi: 10.1371/journal.pone.0109702. eCollection 2014.

2014
ASL Torino 5

Cercone S; Nicolucci A; Cucinotta D; Giorda CB; Russo GT;

Erratum to: Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature (Endocrine DOI: 10.1007/s12020-014-0179-0) in Endocrine

2014
ASL Torino 5

Giorda CB; Nada E; Tartaglino B;

The role of the care model in modifying prognosis in diabetes. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2013 Jan;23(1):11-6. doi: 10.1016/j.numecd.2012.07.001. Epub 2012 Aug 18.

2013
ASL Torino 5

Giorda CB;

Predictors of beta cell dysfunction in type 2 diabetes: The Beta Decline study in Diabetologia

2013
ASL Asti
ASL Torino 5

Russo GT; Arcangeli A; Cercone S; Corda A; Cucinotta D; De Cosmo S; Gentile L; Leotta S; Nicolucci A; Pellegrini M; Vespasiani G; Giorda CB;

The SUBITO-DE study: Sexual dysfunction in newly diagnosed Type 2 diabetesmale patients in Journal of Endocrinological Investigation

2013
ASL Torino 5

Corona G; Giorda CB; Cucinotta D; Guida P; Nada E; Aglialoro A; Albanese V; Albano S; Antonangelo C; Baccetti F; Bulzomi' R; Calatola P; Capano F; Clemente G; Corigliano G; Cucinotta D; De Fazio C; De Francesco C; De Joannon U; Del Buono A; Fontana L; Fornengo R; Fraticelli E; Gaviglio D; Gentile S; Giorda CB; Giorgianni L; Guarino G; Iannarelli R; et alii...

Cardiovascular biomarkers, cardiac dysfunction, and outcomes in patients with type 2 diabetes: A prospective, multicenter study in Diabetes Care

2013
ASL Torino 5

Masson S; Latini R; Cioffi G; Urso R; Vago T; Lucci D; Mureddu GF; Tarantini L; Faggiano P; Girfoglio D; Velussi M; Maggioni AP; Giorda CB; Comaschi M;

Left ventricular dysfunction and outcome at two-year follow-up in patients with type 2 diabetes: The DYDA study in Diabetes Research and Clinical Practice

2013
ASL Torino 5

Cioffi G; Faggiano P; Lucci D; Maggioni AP; Manicardi V; Travaglini A; Girfoglio D; Masson S; Giorda CB; Velussi M; Di Lenarda A; Verdecchia P; Comaschi M;

To what extent is the new position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 'personalised'? in Diabetologia / Diabetologia. 2012 Oct;55(10):2853-2855. doi: 10.1007/s00125-012-2642-x. Epub 2012 Jul 17.

2012
ASL Torino 5

Giorda CB; De Micheli A; Gentile S; Ceriello A; Gallo M;

The implementation of international standardization of glycated hemoglobin. A "red-letter-day" for glycated hemoglobin in Italy: 1/1/11 - Italian recommendations of GLAD Working Group (A1c delegates WG) in Journal of Endocrinological Investigation

2012
ASL Città di Torino
ASL Torino 5

Mosca A; Iafusco D; Meschi F; Branca MT; Carta M; Genna ML; Giorda CB; Ghidelli R; Ghislandi G; Lapolla A; Buondonno Lombardi V; Lovagnini CA; Marra M; Medea G; Pizzini A; Rossi F; Scalpone R; Tofini G; Trovati M; Zaninotto M;

Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events: A randomized controlled trial in Nutrition, Metabolism and Cardiovascular Diseases

2012
ASL Torino 5

Vaccaro O; Masulli M; Bonora E; Del Prato S; Giorda CB; Maggioni AP; Mocarelli P; Nicolucci A; Rivellese AA; Squatrito S; Riccardi G;

Management of newly diagnosed patients with type 2 diabetes: What are the attitudes of physicians? A SUBITO!AMD survey on the early diabetes treatment in Italy in Acta Diabetologica

2012
ASL Torino 5

Suraci C; Mulas F; Rossi MC; Gentile S; Giorda CB;

Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: The DYDA study in European Journal of Preventive Cardiology

2012
ASL Torino 5

Cioffi G; Giorda CB; Chinali M; Di Lenarda A; Faggiano P; Lucci D; Maggioni AP; Masson S; Mureddu GF; Tarantini L; Velussi M; Comaschi M;

Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study. in European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology / Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):415-23. doi: 10.1177/1741826710389402. Epub 2011 Feb 2

2011
ASL Torino 5

Tarantini L; Maggioni AP; Lucci D; Latini R; Cioffi G; Verdecchia P; de Simone G; Di Lenarda A; Faggiano P; Velussi M; Giorda CB; Comaschi M;

The impact of diabetes mellitus on healthcare costs in Italy. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2011 Dec;11(6):709-19. doi: 10.1586/erp.11.78.

2011
ASL Torino 5

Giorda CB; Manicardi V; Diago Cabezudo J;

Use of electronic support for implementing global cardiovascular risk management: Analysis of the evaluation of final feasible effect of control training and ultra-sensitisation (EFFECTUS) educational programme in High Blood Pressure and Cardiovascular Prevention

2011
ASL Torino 5

Tocci G; Ferrucci A; Guida P; Avogaro A; Comaschi M; Corsini A; Cortese C; Giorda CB; Manzato E; Medea G; Mureddu GF; Riccardi G; Titta G; Ventriglia G; Zito GB; Volpe M;

An analysis of the management of cardiovascular risk factors in routine clinical practice in Italy: An overview of the main findings of the EFFECTUS study in High Blood Pressure and Cardiovascular Prevention

2011
ASL Torino 5

Tocci G; Ferrucci A; Guida P; Avogaro A; Comaschi M; Corsini A; Cortese C; Giorda CB; Manzato E; Medea G; Mureddu GF; Riccardi G; Titta G; Ventriglia G; Zito GB; Volpe M;

Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study in Journal of Hypertension

2011
ASL Torino 5

Cioffi G; Faggiano P; Lucci D; Di Lenarda A; Mureddu GF; Tarantini L; Verdecchia P; Comaschi M; Giorda CB; Velussi M; Chinali M; Latini R; Masson S; De Simone G;

Could clinical inertia in part explain the unexpected association of insulin therapy with poorer cardiovascular outcomes in observational studies on diabetes? in Diabetes Research and Clinical Practice

2011
ASL Torino 5

Giorda CB;

Recommendations for the implementation of international standardization of glycated hemoglobin in Italy in Clinical Chemistry and Laboratory Medicine

2010
ASL Torino 5
ASL Città di Torino

Mosca A; Branca MT; Carta M; Genna ML; Giorda CB; Ghidelli R; Ghislandi G; Iafusco D; Lapolla A; Lombardi VB; Lovagnini Scher CA; Marra M; Medea G; Meschi F; Pizzini A; Rossi F; Scalpone R; Tofini G; Trovati M; Zaninotto M;

Use of electronic support for implementing global cardiovascular risk management: Analysis of the evaluation of final feasible effect of control training and ultra sensitisation (EFFECTUS) educational programme in High Blood Pressure and Cardiovascular Prevention

2010
ASL Novara
ASL Torino 5

Tocc G; Avogaro A; Comaschi M; Corsini A; Cortese C; Giorda CB; Guida P; Medea G; Mureddu GF; Titta G; Ventriglia G; Zito GB; Manzato E; Ferrucci A; Volp M;

Association of physicians' accuracy in recording with quality of care in cardiovascular medicine. in European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology / Eur J Cardiovasc Prev Rehabil. 2009 Dec;16(6):722-8. doi: 10.1097/HJR.0b013e3283317c3f.

2009
ASL Torino 5

Giorda CB; Guida P; Avogaro A; Cortese C; Mureddu GF; Corsini A; Comaschi MA; Manzato E; Volpe M; Zito GB; Medea G; Ventriglia G; Titta G; Riccardi G;

Recommendations for the implementation of the international standardization of glycated hemoglobin measurement in Italy in Giornale Italiano di Diabetologia e Metabolismo

2009
ASL Città di Torino
ASL Torino 5

Mosca A; Branca MT; Carta M; Genna ML; Giorda CB; Ghidelli R; Ghislandi G; Iafusco D; Lapolla A; Buondonno Lombardi V; Lovagnini Scher CA; Marra M; Medea G; Meschi F; Pizzini A; Rossi F; Scalpone R; Tofini G; Trovati M; Zaninotto M;

Recommendations for the implementation of the international standardization of glycated hemoglobin in Italy in Rivista Italiana della Medicina di Laboratorio

2009
ASL Città di Torino
ASL Torino 5

Global cardiovascular risk assessment in different clinical settings: Basal results of the EFFECTUS (Evaluation of Final Feasible Effect of Control Training and Ultra-Sensitisation) programme in High Blood Pressure and Cardiovascular Prevention

2009
ASL Torino 5

Volpe M; Tocci G; Avogaro A; Comaschi M; Corsini A; Cortese C; Giorda CB; Guida P; Medea G; Mureddu GF; Titta G; Ventriglia G; Zito GB; Manzato E;

Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors. in Diabetes care / Diabetes Care. 2008 Nov;31(11):2154-9. doi: 10.2337/dc08-1013. Epub 2008 Sep 9.

2008
ASL Torino 5

Giorda CB; Avogaro A; Maggini M; Lombardo F; Mannucci E; Turco S; Alegiani SS; Raschetti R; Velussi M; Ferrannini E;

Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. in Stroke / Stroke. 2007 Apr;38(4):1154-60. doi: 10.1161/01.STR.0000260100.71665.2f. Epub 2007 Mar 1.

2007
ASL Torino 5

Giorda CB; Avogaro A; Maggini M; Lombardo F; Mannucci E; Turco S; Alegiani SS; Raschetti R; Velussi M; Ferrannini E;